The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation January 4, 2023 8:00 AM EST TAIPEI,Taiwan–(BUSINESS WIRE)–PharmaEssentia Corporation, (TPEx:6446), a global biopharmaceutical innovator headquartered in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, today announced […]
23andMe Ordered by the FDA to Halt Sales of Genetic Test
Google backed Genetic Test Maker 23andMe told to Halt Sales by the Food and Drug Administration (FDA) As most readers know, 23andMe offered genetic testing for free to further research for MPN patients. A noble gesture indeed. I readily participated and found the highly detailed report very thought provoking, but perhaps “missing the mark” in […]
JAK2 p.V617F detection and allele burden measurement in peripheral blood and bone marrow aspirates in patients with myeloproliferative neoplasms
Key points The sensitivity and specificity of detecting the JAK2 p.V617F mutation in peripheral blood are both 100% compared to bone marrow. The JAK2 p.V617F allele burden measured in peripheral blood is equivalent to that in bone marrow aspirate (R2=0.991; P<0.0001). See the Abstract Here
Dr Silver on the Curability of Polycythemia Vera with Interferon
Dr. Richard Silver delivers a stellar presentation – On the “Curability” of Polycythemia Vera with Interferon. Presented February 2013, Mayo Clinic, Scottsdale, Arizona. Richard Silver PV
